Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men.
UNLABELLED: Recombinant human erythropoietin (rHuEpo) increases haemoglobin mass (Hb(mass)) and maximal oxygen uptake (v O(2 max)). PURPOSE: This study defined the time course of changes in Hb(mass), v O(2 max) as well as running time trial performance following 4 weeks of rHuEpo administration to d...
Main Authors: | Jérôme Durussel, Evangelia Daskalaki, Martin Anderson, Tushar Chatterji, Diresibachew H Wondimu, Neal Padmanabhan, Rajan K Patel, John D McClure, Yannis P Pitsiladis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3571963?pdf=render |
Similar Items
-
Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration
by: Guan Wang, et al.
Published: (2017-11-01) -
Cross-platform transcriptomic profiling of the response to recombinant human erythropoietin
by: Guan Wang, et al.
Published: (2021-11-01) -
Detection of iron deficiency anaemia by retic haemoglobin
(ret-he) in haemodialysis patients on recombinant human
erythropoietin (rHuEPO).
by: Ehram, Jamian
Published: (2010) -
Interpretation of erythropoietin and haemoglobin levels in patients with various stages of chronic kidney disease
by: Panjeta Mirsad, et al.
Published: (2017-01-01) -
Characteristics of erythropoietin antibodies in patients treated with recombinant human erythropoietin
by: A. M. Kudryashova, et al.
Published: (2020-01-01)